Skip to content
Top Globe News – Lifestyle
Author:
Siren Biotechnology, Inc.
Siren Biotechnology Appoints Former FDA CBER Oncology Branch Chief to Clinical and Scientific Advisory Board
October 14, 2026
Siren Biotechnology Awarded $8M in Non-Dilutive Grant Funding from the California Institute for Regenerative Medicine (CIRM) to Support Clinical Development of SRN-101 in High-Grade Glioma
June 26, 2026
Siren Biotechnology Publishes Foundational AAV Immuno-Gene Therapy Data and Announces Presentations at ASGCT 2026
April 29, 2026